Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cervomed Inc (CRVO)

Cervomed Inc (CRVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 54,870
  • Shares Outstanding, K 8,703
  • Annual Sales, $ 9,740 K
  • Annual Income, $ -16,290 K
  • EBIT $ -21 M
  • EBITDA $ -21 M
  • 60-Month Beta -0.75
  • Price/Sales 5.25
  • Price/Cash Flow N/A
  • Price/Book 1.48

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.57
  • Number of Estimates 2
  • High Estimate -0.39
  • Low Estimate -0.75
  • Prior Year -0.27
  • Growth Rate Est. (year over year) -111.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.45 +21.83%
on 07/03/25
8.30 -20.00%
on 06/10/25
-1.10 (-14.21%)
since 06/09/25
3-Month
5.45 +21.83%
on 07/03/25
11.79 -43.68%
on 05/02/25
-2.20 (-24.89%)
since 04/09/25
52-Week
1.80 +268.89%
on 12/17/24
20.63 -67.81%
on 09/13/24
-8.63 (-56.52%)
since 07/09/24

Most Recent Stories

More News
CervoMed Announces Late-Breaking Presentations at Alzheimer’s Association® International Congress 2025

CRVO : 6.64 (+5.31%)
CervoMed Announces New Hire to Support Neflamapimod Development and Commercialization

CRVO : 6.64 (+5.31%)
CervoMed Reports First Quarter 2025 Financial Results and Provides Corporate Updates

CRVO : 6.64 (+5.31%)
CervoMed to Participate in H.C. Wainwright 3rd Annual BioConnect Investor Conference

CRVO : 6.64 (+5.31%)
Investigators to Present Clinical Trial Results Showing Neflamapimod Slows Clinical Progression in Dementia with Lewy Bodies in Oral Presentation at AD/PDâ„¢ 2025

CRVO : 6.64 (+5.31%)
CervoMed Announces Oral Presentation at 19th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurologic Disorders (AP/PD™)

CRVO : 6.64 (+5.31%)
CervoMed Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Updates

CRVO : 6.64 (+5.31%)
CervoMed Announces Positive Results from the Extension Phase of its Phase 2b Clinical Study of Neflamapimod in Patients with Dementia with Lewy Bodies

CRVO : 6.64 (+5.31%)
CervoMed Provides Update on Neflamapimod DLB Program as Part of Presentation at the 8th International Lewy Body Dementia Conference

CRVO : 6.64 (+5.31%)
CervoMed to Present at the 8th International Lewy Body Dementia Conference

CRVO : 6.64 (+5.31%)

Business Summary

CervoMed Inc. is a clinical-stage biotechnology company advancing CNS-focused therapeutics for patients with a range of degenerative diseases of the brain. The Company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant which inhibits p38MAP kinase...

See More

Key Turning Points

3rd Resistance Point 7.37
2nd Resistance Point 7.06
1st Resistance Point 6.85
Last Price 6.64
1st Support Level 6.34
2nd Support Level 6.03
3rd Support Level 5.82

See More

52-Week High 20.63
Fibonacci 61.8% 13.44
Fibonacci 50% 11.21
Fibonacci 38.2% 8.99
Last Price 6.64
52-Week Low 1.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar